Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2011
06/14/2011US7960396 Inhibitors of Bruton's tyrosine kinase
06/14/2011US7960395 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors
06/14/2011US7960382 Compounds and their use related to compositions for treating disease
06/14/2011US7960377 Substituted pyridoxazines
06/14/2011US7960374 e.g. 2,5-methylene-9-(phenylsulfonyl)-1,2,3,4,5,9-hexahydro[1,5]oxazocino[3,2-e]indole; serotonin receptors antagonist or partial agonist; metabolic diseases, e.g. obesity, insulin resisitance, type 2 diabetes, eating disorders; antidepressant, anxiolytic agent; cosmetics
06/14/2011US7960371 High-purity large-scale preparation of stannsoporfin
06/14/2011US7960181 Chromoionophore and method of determining potassium ions
06/14/2011CA2619897C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
06/14/2011CA2494962C Tyrosine kinase inhibitors
06/14/2011CA2452752C Dye-azide compounds for dual phototherapy
06/09/2011WO2011067571A1 Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor
06/09/2011WO2011067365A1 Benzpyrazole derivatives as inhibitors of p13 kinases
06/09/2011WO2011067185A1 Spiroindolinone pyrrolidines
06/09/2011WO2011067145A1 Tricyclopyrazole derivatives
06/09/2011WO2011006143A3 Fused imidazoles and compositions comprising them for the treatment of parasitic diseases, such as e.g. malaria
06/09/2011WO2009010791A3 Cyclic ethers
06/09/2011US20110137031 Pyrrolopyrimidine and pyrrolotriazine derivatives
06/09/2011US20110137028 Methods of synthesis and purification of heteroaryl compounds
06/09/2011US20110137025 Chemical framework compositions and methods of use
06/09/2011US20110137024 Method for producing isoindole
06/09/2011US20110136812 Solubilized topoisomerase poisons
06/09/2011US20110136781 Imidazotriazines and imidazopyrimidines as kinase inhibitors
06/09/2011US20110136778 Nitrogen-containing spirocyclic compounds and pharmaceutical uses thereof
06/09/2011US20110136774 Anti-Apoptotic Benzodiazepine Receptor Ligand Inhibitors
06/09/2011US20110136765 Pyrrolo[2,3-D]Pyrimidine Compounds
06/09/2011US20110135668 Compounds and compositions as protein kinase inhibitors
06/09/2011US20110135601 Bicycloaniline derivative
06/09/2011US20110133173 Charge transport compositions and electronic devices made with such compositions
06/09/2011CA2781891A1 Novel tricyclic compounds
06/09/2011CA2781823A1 Spiroindolinone pyrrolidines
06/09/2011CA2781182A1 Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor
06/09/2011CA2781010A1 Novel tricyclic compounds
06/08/2011EP2328898A1 2-heteroaryl-pyrrolo [3, 4-c]pyrrole derivatives and the use thereof as scd inhibitors
06/08/2011EP2328897A1 Bicyclic heterocycle derivatives and their use as gpcr modulators
06/08/2011EP2328890A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
06/08/2011EP2328876A1 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists
06/08/2011EP2328871A2 Hedgehog pathway modulators
06/08/2011EP2328865A1 Hepatitis c virus inhibitors
06/08/2011EP2328412A1 Iap inhibitors
06/08/2011EP2188290B1 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents
06/08/2011EP2044054B1 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity
06/08/2011EP1948664B1 Pyrrolotriazine kinase inhibitors
06/08/2011EP1879895B1 Enzyme inhibitors
06/08/2011EP1874777B1 1h-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use
06/08/2011EP1670801B1 Pyrazolo and imidazo-pyrimidine derivatives
06/08/2011CN102089309A Pyrrolobenzodiazepines
06/08/2011CN102089286A Chemical compounds
06/08/2011CN102086205A 1,3-disubstituted-7-azabicyclo [2.2.1]heptane derivatives and preparation method thereof
06/08/2011CN102086204A Industrialized production method of high-purity pemetrexed disodium
06/08/2011CN102086203A Preparation method of tetraazadecalin
06/08/2011CN102086202A Method for quickly preparing cis-octahydropyrrolo[3,2-b]pyrrole
06/08/2011CN102086201A Method for quickly synthesizing cis-octahydropyrrolo[3,2-b]pyrrole
06/08/2011CN102086200A Method for quickly synthesizing cis-octahydropyrrolo[3,2-b]pyrrole
06/08/2011CN101510590B Organic electroluminescent element and display
06/08/2011CN101203522B Antineoplastic compounds and pharmaceutical compositions thereof
06/08/2011CN101190916B Anticancer compound, preparation method and use thereof, and composition containing the compound
06/08/2011CN101058581B Method of preparing eszopiclone intermediate 6-(5-chloro-2-pyridyl)-5,7-dioxy-6,7-dihydro-5H-pyrrolo[3,4-b] pyrazine
06/07/2011US7956195 reacting arylboronic acids with a cycloalkanone, in the presence of a rhodium catalyst or BINAP, to form a substituted arylcycloalkanone, then formin of a hydantoin, alkylation of the hydantoin, resolution, hydrolysis of the hydantoin to the amino acids and esterification of acids; chemical intermediates
06/07/2011US7956194 Microbiocidal (E.G. fungicidal) 1,2,3-triazole derivatives
06/07/2011US7956084 Phenyl thiophene carboxamide compounds as inhibitors of the enzyme IKK-2
06/07/2011US7956082 Indole derivative having PGD2 receptor antagonist activity
06/07/2011US7956079 Antihepatitis C virus agent and anti-HIV agent
06/07/2011US7956062 Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
06/07/2011US7956061 Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
06/07/2011US7956060 Pyrimidine derivative compound
06/07/2011US7956058 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
06/07/2011US7956049 Melanin concentrating hormone receptor-1 antagonists
06/07/2011US7955859 Fluorescent labeling compound
06/07/2011CA2581025C Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
06/07/2011CA2555824C Fused-ring 4-oxopyrimidine derivative
06/07/2011CA2483164C Pyrrolo-triazine aniline compounds useful as kinase inhibitors
06/03/2011WO2011064376A1 Imidazole derivatives as aldosterone synthase inhibitors
06/03/2011WO2011064256A1 A new crystalline form of pemetrexed disodium
06/03/2011WO2011064237A1 Crystalline forms of substituted pyrazolopyrimidines
06/03/2011WO2011064211A1 Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls
06/03/2011WO2011063502A1 Hepatitis c inhibitor compounds
06/03/2011WO2011063501A1 Hepatitis c inhibitor compounds
06/03/2011WO2011017108A3 Cyclopropyl modulators of p2y12 receptor
06/03/2011WO2011008572A3 5-ht3 receptor modulators, methods of making, and use thereof
06/03/2011WO2006119507A3 Non-nucleotide composition and method for inhibiting platelet aggregation
06/03/2011CA2782024A1 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
06/03/2011CA2776361A1 Crystalline forms of substituted pyrazolopyrimidines
06/02/2011US20110130538 Photolytic acid-generating polymers and monomers for their construction
06/02/2011US20110130414 Novel fused thiazolo and oxazolo pyrimidinones
06/02/2011US20110130412 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
06/02/2011US20110130400 Trpv4 antagonists
06/02/2011US20110130398 Spiroindolinone pyrrolidines
06/02/2011US20110130397 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof
06/02/2011US20110130389 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
06/02/2011US20110130384 Amide compound
06/02/2011US20110130382 Modulators of 5-ht receptors and methods of use thereof
06/02/2011US20110130364 Pyrrolopyridine derivatives substituted with cyclic amino group
06/02/2011US20110129896 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3Beta PROTEIN AND PROTEIN COMPLEXES
06/01/2011EP2327704A1 Ring-fused azole derivative having pi3k-inhibiting activity
06/01/2011EP2326650A2 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
06/01/2011EP2326649A1 Novel pyrrolo ý2,3-a¨carbazoles and use thereof as pim kinase inhibitors
06/01/2011EP2326644A1 Urotensin ii receptor antagonists
06/01/2011EP2326638A1 Diazepine and diazocane compounds as mc4 agonists
06/01/2011EP2326636A2 Pyrazole carboxamide inhibitors of factor xa
06/01/2011EP2253634A9 Liquid porphyrin derivative and method for producing the same